TAT-cyclo-CLLFVY

Pricing Availability   Qty
Cat.No. 5582 - TAT-cyclo-CLLFVY | cyclo(Cys-Leu-Leu-Phe-Val-Tyr) Cys-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Pro-Pro-Gln | CAS No. 1446322-66-2
Description: Selective HIF-1 dimerization inhibitor
Datasheet
Citations
Reviews
Literature

Biological Activity

Selective HIF-1 dimerization inhibitor. Blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β (IC50 = 1.3 μM). Inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cancer cells in vitro. Also reduces tubularization of hypoxic HUVECs.

Technical Data

M. Wt 2559.1
Formula C111H188N42O24S2
Sequence CLLFVY CGRKKRRQRRRPPQ*

(Modifications: Lactam bridge: Cys-1 to Tyr-6), Disulfide bridge: 1-1*)

Storage Store at -20°C
CAS Number 1446322-66-2
PubChem ID 72192490
InChI Key AWUUHEHYNQGEFC-XLZVTALKSA-N
Smiles [H]N[C@@H](CSSC[C@@H]1N([H])C(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC1=O)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Solubility Data

Solubility Soluble to 1 mg/ml in water

Product Datasheets

Certificate of Analysis / Product Datasheet
Select another batch:

References

References are publications that support the biological activity of the product.

Miranda et al (2013) A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells. J.Am.Chem.Soc. 135 10418 PMID: 23796364


If you know of a relevant reference for TAT-cyclo-CLLFVY, please let us know.

View Related Products by Product Action

View all Hypoxia Inducible Factor Inhibitors

Keywords: TAT-cyclo-CLLFVY, TAT-cyclo-CLLFVY supplier, HIF-1a, 1b, 1beta, 1alpha, α, β, hypoxia, inducible, factor, cancer, angiogenesis, antiangiogenic, dimerization, inhibitors, inhibits, Hypoxia, Inducible, Factors, 5582, Tocris Bioscience

Citations for TAT-cyclo-CLLFVY

Citations are publications that use Tocris products.

Currently there are no citations for TAT-cyclo-CLLFVY. Do you know of a great paper that uses TAT-cyclo-CLLFVY from Tocris? Please let us know.

Reviews for TAT-cyclo-CLLFVY

There are currently no reviews for this product. Be the first to review TAT-cyclo-CLLFVY and earn rewards!

Have you used TAT-cyclo-CLLFVY?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Cancer

Cancer Research Product Guide

A collection of over 750 products for cancer research, the guide includes research tools for the study of:

  • Cancer Metabolism
  • Epigenetics in Cancer
  • Receptor Signaling
  • Cell Cycle and DNA Damage Repair
  • Angiogenesis
  • Invasion and Metastasis
Angiogenesis in Cancer

Angiogenesis in Cancer Poster

Adapted from the 2015 Cancer Product Guide, Edition 3, this poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.